Balaji Amines just held its Q2FY26 earnings call, and no, this wasn’t a fireworks show. More like a slow-burning lab experiment—stable, controlled, and waiting for the reaction to kick in. While everyone else is panicking about demand, Balaji calmly told the market, “Margins first, volumes later.”
Revenue dipped quarter-on-quarter, volumes barely moved, yet EBITDA margins quietly improved. EV-linked products? Ready. Customers? Still stretching. Government approvals? Doing their usual bureaucratic yoga.
Management sounds confident, patient, and slightly tired of waiting for battery manufacturers to wake up. The stock market, meanwhile, is still deciding whether patience is a virtue or a cost.
Stick around. The real masala is hidden in DME approvals, battery-grade chemicals, and a ₹750 crore specialty bet that refuses to hurry. Things get interesting once the plants actually start running.
2. At a Glance
Revenue ₹341 cr – Flat is the new growth when demand refuses to cooperate.
EBITDA ₹67 cr – Margins stretched to 19%, chemistry still works.
PAT ₹37 cr – Déjà vu from last quarter, profits stuck in a loop.
Volumes 26,165 MT – Steady as she goes, no acceleration yet.
Net Debt Zero – Balance sheet flex, no banker drama here.
3. Management’s Key Commentary
“The operating environment was mixed with moderated demand.” (Translation: Customers are ordering… just not enthusiastically 😏)
“We sustained healthy margins despite challenges.” (Margins wore safety goggles and survived the reaction 💥)
“We remain a zero-debt company.” (Sleep well, no EMI stress 😌)
“DME approvals are moving table to table in the Government.” (File stuck in bureaucratic relay race 🏃♂️)
“Battery manufacturers are yet to take full swing.” (EV hype > EV reality, for now 🔋)
